CRSP SCHEDULE 13G/A: SEC filing
Orbis Investment Management Ltd
Filed with the SEC on · accession 0000940594-26-000069
CRSP filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. Orbis Investment Management Ltd filed an amended Schedule 13G reporting beneficial ownership of 4,501,782 shares (4.7%) of CRISPR Therapeutics AG, alongside Allan Gray Australia Pty Ltd which holds 17,479 shares. The stock moved -4.4% by the first close after the filing.
Summary of the filing
Orbis Investment Management Ltd filed an amended Schedule 13G reporting beneficial ownership of 4,501,782 shares (4.7%) of CRISPR Therapeutics AG, alongside Allan Gray Australia Pty Ltd which holds 17,479 shares. The filing is a passive institutional ownership disclosure with no stated intent to influence control.
Key details
How CRSP stock reacted
Close before
$42.24
Nov 13, 2026
First close after
-4.43%
$40.37
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for CRSP, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CRSP?
Click hereFrequently asked questions
What did CRSP file with the SEC on Nov 16, 2026?
CRSP filed a SCHEDULE 13G/A (SEC filing). Orbis Investment Management Ltd filed an amended Schedule 13G reporting beneficial ownership of 4,501,782 shares (4.7%) of CRISPR Therapeutics AG, alongside Allan Gray Australia Pty Ltd which holds 17,479 shares. The filing is a passive institutional ownership disclosure with no stated intent to influence control.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did CRSP stock react to this filing?
CRSP closed at $42.24 before the filing and $40.37 on Nov 16, 2026 (-4.43%).
Other CRSP SEC filings
- SCHEDULE 13G/A · SEC filingNov 13, 2026
- SCHEDULE 13G · SEC filingNov 10, 2026
- 8-K · SEC filingNov 2, 2026
- 10-Q · SEC filingNov 2, 2026
- 8-K · Cfo changeOct 19, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 10-Q · SEC filingAug 3, 2026
- 8-K · SEC filingAug 3, 2026
- 8-K · SEC filingJun 4, 2026
- 8-K · SEC filingMay 4, 2026
Get alerts when CRSP files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days